A detailed history of Scs Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Scs Capital Management LLC holds 8,058 shares of BMY stock, worth $377,517. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,058
Previous 8,058 -0.0%
Holding current value
$377,517
Previous $491,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$53.9 - $63.11 $434,326 - $508,540
8,058 New
8,058 $491,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Scs Capital Management LLC Portfolio

Follow Scs Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scs Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scs Capital Management LLC with notifications on news.